-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Neuraminidase-IN-9
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/2217630-64-1.gif)
| Category | Influenza Virus |
| CAS | 2217630-64-1 |
| Description | Neuraminidase-IN-9 (Compound 6l) is a potent influenza neuraminidase inhibitor with IC50 values of 0.12, 0.049 and 0.16 µM against H5N1, H5N2 and H5N6, respectively. |
Product Information
| Synonyms | Neuraminidase-IN-9|CHEMBL4468358|BDBM50526911|HY-146306|CS-0498119 |
| Molecular Weight | 533.46 |
| Molecular Formula | C24H33BrN6O3 |
| Canonical SMILES | CCC(CC)OC1C=C(CC(C1NC(=O)C)N)C(=O)NCC2=CN(N=N2)CC3=CC=C(C=C3)Br |
| Purity | ≥98% (HPLC) |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 711 |
| Exact Mass | 532.17975 |
| Target | IC50: 0.049 µM (H5N2), 0.12 µM (H5N1), 0.16 µM (H5N6) EC50: 0.43 µM (H5N2), 2.45 µM (H5N1), 2.8 µM (H5N6) |
| XLogP3-AA | 1.7 |
